| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/31/2011 | US20110076286 Methods of inhibiting unwanted cell proliferation using hedgehog antagonists |
| 03/31/2011 | US20110076285 Methods and Compositions For Treatment of Ocular Fibrosis |
| 03/31/2011 | US20110076283 Method for predicting and diagnosing brain tumor |
| 03/31/2011 | US20110076278 Modulators of Hypoxia Inducible Factor-1 and Related Uses for the Treatment of Ocular Disorders |
| 03/31/2011 | US20110076276 Novel HIV reverse transcriptase inhibitors |
| 03/31/2011 | US20110076274 Materials and methods relating to a g-protein coupled receptor |
| 03/31/2011 | US20110076272 Therapeutic methods and compositions |
| 03/31/2011 | US20110076271 Diagnostic methods and compositions for treatment of cancer |
| 03/31/2011 | US20110076261 Antifungal Drug Delivery System |
| 03/31/2011 | US20110076258 Methods of modulating t cell- dependent immune responses |
| 03/31/2011 | US20110076252 Compound and method for treatment of gastroesophageal reflux |
| 03/31/2011 | US20110076251 Novel therapeutic agents against hepatitis |
| 03/31/2011 | US20110076250 Biodegradable Absorbents and Methods of Preparation |
| 03/31/2011 | US20110076249 Immunotherapy for immune suppressed patients |
| 03/31/2011 | US20110076246 Thiol-containing compounds for the removal of elements from contaminated milieu and methods of use |
| 03/31/2011 | US20110076244 Surface coatings for skin |
| 03/31/2011 | US20110076243 Modified hydrophilic polymers containing hydrophobic groups |
| 03/31/2011 | US20110076240 Antifungal and Anti-Cariogenic Cellobio-Oligosaccharides Produced by Dextransucrase |
| 03/31/2011 | US20110076238 Compounds for the treatment of proliferative processes |
| 03/31/2011 | US20110076236 Compositions and methods of treatment using modulators of motoneuron diseases |
| 03/31/2011 | US20110076235 Genes, methods, and compositions related to neurogenesis and its modulation |
| 03/31/2011 | US20110076231 Temporary embolization using inverse thermosensitive polymers |
| 03/31/2011 | US20110076230 Novel Substituted Indoles |
| 03/31/2011 | US20110073518 Generally Linear Effervescent Oral Fentanyl Dosage Form and Methods of Administering |
| 03/31/2011 | DE112009000125T5 Verwendung einer Zusammensetzung eines Kranbeeren-Derivats und D-Mannose, um Harnwegsinfektionen zu verhindern, zu kontrollieren und zu verbessern In order to prevent urinary tract infections to control use of a composition of a cranberry derivative and D-mannose, and to improve |
| 03/31/2011 | CA2812683A1 Lysine specific demethylase-1 inhibitors and their use |
| 03/31/2011 | CA2811154A1 Prostaglandin transporter inhibitors and uses thereof |
| 03/31/2011 | CA2801143A1 Disinfecting agent comprising eugenol, terpineol and thymol |
| 03/31/2011 | CA2775874A1 Combination |
| 03/31/2011 | CA2775697A1 Cyclic peptide inhibitors of hepatitis c virus replication |
| 03/31/2011 | CA2775601A1 4-(substituted anilino)-quinazoline derivatives useful as tyrosine kinase inhibitors |
| 03/31/2011 | CA2775475A1 Pyridinylimidazolone derivatives for inhibition of pi3 kinases |
| 03/31/2011 | CA2775404A1 Formulations comprising triptan compounds |
| 03/31/2011 | CA2775400A1 New use of pdgfrbeta inhibitors |
| 03/31/2011 | CA2775397A1 Thiol-containing compounds for the removal of elements from contaminated milieu and methods of use |
| 03/31/2011 | CA2775350A1 Dr5 ligand drug conjugates |
| 03/31/2011 | CA2775339A1 Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same |
| 03/31/2011 | CA2775328A1 Pyrido[4,3-b]indoles and methods of use |
| 03/31/2011 | CA2775296A1 Polymorphs of sorafenib acid addition salts |
| 03/31/2011 | CA2775216A1 Bridged heterocyclic compounds and methods of use |
| 03/31/2011 | CA2775204A1 Fused imidazo [3, 2 - d] pyraz ines as pi3 kinase inhibitors |
| 03/31/2011 | CA2775133A1 Pyrido[3,4-b]indoles and methods of use |
| 03/31/2011 | CA2775129A1 Pyrido[3,4-b]indoles and methods of use |
| 03/31/2011 | CA2775125A1 Combination |
| 03/31/2011 | CA2775124A1 Combination |
| 03/31/2011 | CA2775111A1 Treatment of filaggrin (flg) related diseases by modulation of flg expression and activity |
| 03/31/2011 | CA2775092A1 Compositions and methods for silencing genes expressed in cancer |
| 03/31/2011 | CA2775039A1 Retinal neuroprotection by ion channel blockers regulated by the sur subunit |
| 03/31/2011 | CA2775027A1 Maleic acid salt and crystal thereof |
| 03/31/2011 | CA2774807A1 Benzoxepin pi3k inhibitor compounds and methods of use |
| 03/31/2011 | CA2774801A1 Use of nicotinic acetylcholine receptor alpha 7 activators |
| 03/31/2011 | CA2774750A1 Treatment and prevention of hiv infection |
| 03/31/2011 | CA2774731A1 Dihydropteridinone derivatives, preparation process and pharmaceutical use thereof |
| 03/31/2011 | CA2774647A1 Substituted amide compound |
| 03/31/2011 | CA2774616A1 Composition and method for treatment of diabetes |
| 03/31/2011 | CA2774569A1 Novel n-benzylamide substituted derivatives of 2-(acylamido)acetic acid and 2-(acylamido)propionic acids: potent neurological agents |
| 03/31/2011 | CA2774558A1 Methods and pharmaceutical compositions for treating down syndrome |
| 03/31/2011 | CA2774387A1 Novel macrocyclic inhibitors of hepatitis c virus replication |
| 03/31/2011 | CA2774332A1 Piperidine and piperazine derivatives as smo antagonists |
| 03/31/2011 | CA2774153A1 Galenic form suitable for absorbing, in a specific manner, the undesirable molecules in the digestive tract |
| 03/31/2011 | CA2774008A1 Toll-like receptor modulators and uses thereof |
| 03/31/2011 | CA2773776A1 Compositions and methods for inducing or enhancing connective tissue repair |
| 03/31/2011 | CA2773306A1 Process |
| 03/31/2011 | CA2773305A1 Crystalline methylthioninium chloride hydrates |
| 03/31/2011 | CA2772691A1 Benzoxazepin pi3k inhibitor compounds and methods of use |
| 03/31/2011 | CA2772284A1 [1,4]-benzodiazepines as vasopressin v2 receptor antagonists |
| 03/31/2011 | CA2772188A1 Gpr 119 modulators |
| 03/31/2011 | CA2771831A1 Oral pharmaceutical composition comprising diclofenac |
| 03/31/2011 | CA2771026A1 Indole derivatives as crac modulators |
| 03/31/2011 | CA2770278A1 Pyrazoline dione derivatives as nadph oxidase inhibitors |
| 03/31/2011 | CA2770087A1 Imidazopyridine or imidazopyrimidine derivatives as phosphodiesterase 1oa inhibitors |
| 03/31/2011 | CA2768523A1 Heterocyclic antiviral compounds |
| 03/31/2011 | CA2760180A1 Pharmaceutical composition for the treatment of mcp-1 mediated inflammatory diseases |
| 03/30/2011 | EP2302062A1 Identification of E2F target genes and uses thereof |
| 03/30/2011 | EP2302059A1 Modifications of hiv Env, Gag, and Pol enhance immunogenicity for genetic immunization |
| 03/30/2011 | EP2302057A1 Control of gene expression |
| 03/30/2011 | EP2302039A1 Virus-like particles comprising HML-2 gag polypeptide |
| 03/30/2011 | EP2301971A1 Antibodies that bind both BCMA and TACI |
| 03/30/2011 | EP2301945A1 Hydrates of erythromycin salts, the preparation and the use thereof |
| 03/30/2011 | EP2301940A1 Epothilone derivatives |
| 03/30/2011 | EP2301939A1 Enzyme inhibitors |
| 03/30/2011 | EP2301938A1 Crystalline of eszopiclone, its composition, preparation and uses thereof |
| 03/30/2011 | EP2301937A1 Prodrugs of A2b adenosine receptor antagonists |
| 03/30/2011 | EP2301936A1 Spirodiamine-diarylketoxime derivative |
| 03/30/2011 | EP2301935A1 Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes |
| 03/30/2011 | EP2301934A1 Nitrocatechol derivatives as COMT inhibitors |
| 03/30/2011 | EP2301931A1 Imidazoles as aldosterone synthase inhibitors |
| 03/30/2011 | EP2301930A1 Thrombin receptor antagonists |
| 03/30/2011 | EP2301929A1 Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes |
| 03/30/2011 | EP2301928A1 Imidazolyl-pyrimidine compounds for use in the treatment of proliferative disorders |
| 03/30/2011 | EP2301923A1 New compounds |
| 03/30/2011 | EP2301922A1 Pyridone compound |
| 03/30/2011 | EP2301916A2 4-aminotetracyclines and methods of use thereof |
| 03/30/2011 | EP2301915A1 7-(diethylamino)methyl substituted tetracycline having target therapeutic activities |
| 03/30/2011 | EP2301914A1 7,9-Substituted tetracycline compounds |
| 03/30/2011 | EP2301913A1 7,9-Substituted tetracycline compounds |
| 03/30/2011 | EP2301912A2 4-aminotetracyclines and methods of use thereof |
| 03/30/2011 | EP2301908A1 (-)-stereoisomer of 2,6-di-sec-butylphenol and analogs thereof for promoting antiemetic effect and treatment of nausea and vomiting |
| 03/30/2011 | EP2301628A1 Methods and reagents for the treatment of immunoinflammatory disorders |
| 03/30/2011 | EP2301627A1 Novel antimalarial 3-azabicyclo[3.2.2]nonane derivatives |